New York University Clinical Cancer Center — New York, New York

Public research footprint of New York University Clinical Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stage III Non-small-cell Lung Cancer · Breast Cancer · Non-Small Cell Lung Cancer (NSCLC) · Unresectable Hepatocellular Carcinoma

Recently updated registry entries

NCT05467891 — Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent… (Recruiting)
NCT04829383 — A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma (Completed)
NCT03767348 — Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at New York University Clinical Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.